Jeffrey Trigilio - Dec 21, 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Financial Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Dec 21, 2023
Transactions value $
-$16,320
Form type
4
Date filed
12/22/2023, 05:30 PM
Previous filing
Dec 20, 2023
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$16.3K -1.92K -2.24% $8.50 83.9K Dec 21, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.